Abbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.

GUIDANCE:

Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.

For earnings history and earnings-related data on Abbott (ABT) click here.